CClinicalTrials.gg
Status unknownNCT01167348Updated Jul 23, 2010

The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia

An interventional study of auricular acupressure in Schizophrenia and Obesity, sponsored by TsaoTun Psychiatric Center, Department of Health, Taiwan. Status unknown at 1 site in Taiwan. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2010-07-23.

Sponsored by TsaoTun Psychiatric Center, Department of Health, Taiwan · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2010), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

The purpose of this study is to examine whether auricular acupressure is effective in reducing body weight, waist circumference, or lipid profile.

02

Conditions studied

  • Schizophrenia
  • Obesity

Keywords

  • auricular acupressure
  • obesity
  • schizophrenia
  • body weight
03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 132 are open to participants now.

This study's planned enrollment of 86 is above the median of 64 across 947 interventional studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

TsaoTun Psychiatric Center, Department of Health, Taiwan is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. ICD:295,living in chronic ward for more than 2 month
  2. Body Mass Index (BMI) >or=24
  3. Age between 20 to 60
  4. Psychotic status stable and can communicate

Exclusion criteria

Exclusion Criteria:

  1. Unstable psychotic status
  2. Participants who have endocrine disease
  3. Participants who have cardiac disease
  4. Participants who have immunological disease
  5. Participants who have liver or renal function impairment
  6. Pregnant woman or in milking stage
  7. Cerebrovascular accident (CVA) stroke and disability
  8. Participant who attends weight control programs in recent 3 months
  9. Any conditions that clinical doctors refuse to let join in this study
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
86 participants (estimated)

Interventions

  • Procedureauricular acupressure

    Investigator will put a tape with a 0.5mmx0.5mm seed on the specific positions on the ear of participants of intervention group, and participants will be asked to press these specific positions 3 times a day.

06

What researchers measure

Primary outcomes

  1. Using Body weight scale (kilogram) and checking body weight for all participants

    all participants are going to be measured body weight per week for 2 months.

    Time frame: 2 months

Secondary outcomes

  1. waist circumference

    All participants are going to be measured waist circumference per week for 2 months.

    Time frame: 2 months

  2. Fat percentage by using bio-Impedance Analysis(Tanita-519 machine)

    All participants will be measured fat percentage by BIA(Tanita-519) per 2 months.

    Time frame: 2 months

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01167348
Lead sponsor
TsaoTun Psychiatric Center, Department of Health, Taiwan
First posted
Jul 22, 2010
Start date
Jun 2010
Primary completion
Aug 2010 (estimated)
Completion
Aug 2010 (estimated)
Last update
Jul 23, 2010

Study contacts

Han-Yi Ching, MD
Contact
HYChing@mail.ttpc.doh.gov.tw
886911587276
Ching Han-Yi, MD
principal investigator · Tsaotun Psychiatric Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion